We ensure that businesses with growth aspirations can access equity finance to reach their potential

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority. We manage £58.5m of regional VC Funds in Northern Ireland including the £47.3m Co-Investment Fund. We have invested in over 100 companies since we began investing in 2001.

The Co-Investment Fund, managed by Clarendon Fund Managers, matches private investment into high-growth potential businesses based in Northern Ireland. We typically initially invest between £50,000 to £250,000 and support growth with follow-on investment.

AuditComply received an initial £125,000 investment from the Co-Investment Fund, managed by Clarendon, in March 2015. Following seven additional follow-on investments that funded development of their innovative risk-management software, AuditComply received a strategic investment from the British Growth Fund and First Derivatives to accelerate growth.

• CO-FUND NI HAS RECENTLY MADE AN INVESTMENT INTO ITS 100TH INVESTEE COMPANY FOLLOWING A DEAL INTO KINSETSU, A FEMALE FOUNDED BELFAST-BASED IT FIRM
• This landmark deal for Co-Fund NI means that it has now deployed capital of £43m, which has helped to leverage £285m of private investment into the Northern Ireland economy, s 18 January, 2023

CO-FUND NI HAS RECENTLY MADE AN INVESTMENT INTO ITS 100TH INVESTEE COMPANY FOLLOWING A DEAL INTO KINSETSU, A FEMALE FOUNDED BELFAST-BASED IT FIRM.

This landmark deal for Co-Fund NI means that it has now deployed capital of £43m, which has helped to leverage £285m of private investment into the Northern Ireland economy, s

• CONGRATULATIONS TO PORTFOLIO COMPANY, RE-VANA THERAPEUTICS, ON SECURING A £10M INVESTMENT One of Queen’s technology spin-out companies, Re-Vana Therapeutics, has attracted £10m of investment for research into sight-threatening eye disease
• Article taken from: https 18 January, 2023

CONGRATULATIONS TO PORTFOLIO COMPANY, RE-VANA THERAPEUTICS, ON SECURING A £10M INVESTMENT

One of Queen’s technology spin-out companies, Re-Vana Therapeutics, has attracted £10m of investment for research into sight-threatening eye disease Article taken from: https

• SAPIEN HEALTH RAISES £2M AND REBRANDS TO SURGERY HERO AS IT EYES US EXPANSION Article taken from: https://www
• lifearc
• org/ Headquartered in London, Surgery Hero is a digital clinic that helps people prepare for and recover from surgery at home
• The £2 m 15 November, 2022

SAPIEN HEALTH RAISES £2M AND REBRANDS TO SURGERY HERO AS IT EYES US EXPANSION

Article taken from: https://www lifearc org/ Headquartered in London, Surgery Hero is a digital clinic that helps people prepare for and recover from surgery at home The £2 m